Suchergebnisse - "Gao, Leili"

PubPharm (6)

1

A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy

enthalten in: Diabetes, obesity & metabolism | 2023

von Ji, L. | Lu, J. | Gao, L. | +12

2

Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes : A randomized, double-blind, placebo-controlled phase 3 trial

enthalten in: Diabetes, obesity & metabolism | 2023

von Ji, L. | Lu, J. | Gao, L. | +12

3

The effects of daily dose and treatment duration of metformin on the prevalence of vitamin B12 deficiency and peripheral neuropathy in Chinese patients with type 2 diabetes mellitus : A multicenter cross-sectional study

enthalten in: Journal of diabetes | 2023

von Gao, L. | Ran, X. | Liu, X. | +10

4

Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone : A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial

enthalten in: Diabetes, obesity & metabolism | 2023

von Gao, L. | Cheng, Z. | Su, B. | +15

5

A multicentre, randomized, double-blind, parallel, active- and placebo-controlled Phase 3 clinical study of the glucokinase activator PB-201 in treatment-naive patients with type 2 diabetes mellitus : A study protocol

enthalten in: Diabetes, obesity & metabolism | 2023

von Du, Y. | Gao, L. | Xiao, X. | +2

6

Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes : results from the Observational Registry of Basal Insulin Treatment (ORBIT)

enthalten in: Journal of diabetes | 2020

von Gao, L. | Zhang, P. | Weng, J. | +13

1
[1]